Viewing nowMicardis 40 mg Tablets (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

MFDS item code 199907012 · Approved 1999.10.22 · Insurance code 653500340
Treatment of essential hypertension; reduction and prevention of cardiovascular disease risk
This medication is used for the treatment of essential hypertension. Additionally, it helps reduce the risk of myocardial infarction, stroke, and death due to cardiovascular disease in patients over 55 years of age who are at high risk for cardiovascular disease, especially those with a history of coronary artery disease, peripheral artery disease, stroke, or transient ischemic attack, as well as patients with diabetes at high risk evidenced by signs of end-organ damage. Therefore, this drug is used to manage hypertension while improving cardiovascular health.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine provides an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The effect of reducing the risk of cardiovascular morbidity and mortality at doses below 80 mg is unknown. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This drug can cause severe harm to the fetus and newborn during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug or its components, pregnant or breastfeeding women, patients with severe liver disease or biliary excretion disorders, patients with hereditary angioedema, and patients with diabetes or severe renal impairment should not take this medication. Caution is advised for elderly patients, patients with hyperkalemia, patients with mild to moderate liver dysfunction, patients with heart valve disease, patients with ischemic heart disease, patients with gastrointestinal disorders, patients with renovascular hypertension, and patients with severe renal impairment. Blood pressure, renal function, and serum potassium levels should be regularly monitored during treatment, especially when this medication is used in combination with other blood pressure medications or potassium supplements. Side effects such as dizziness, headache, cough, dyspepsia, skin rash, angioedema, myalgia, renal function abnormalities, etc. may occur, so if any unusual symptoms arise, consult a healthcare professional immediately. This medication lowers blood pressure, and in the event of hypotension, measures such as laying the patient down and administering fluids may be necessary. It is advisable not to take this medication for 24 hours before surgery, and caution is required when driving or operating machinery due to the risk of dizziness or fainting. This medication contains sorbitol and is not suitable for patients with fructose intolerance. Women who are pregnant or planning to become pregnant should not take this medication, and breastfeeding women should also avoid it. In cases of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur; therefore, if symptoms arise, seek medical attention immediately. The safety and efficacy for children and adolescents under 18 years of age have not been established and are not recommended. This drug may enhance the blood-lowering effect when used in combination with other antihypertensive medications, and may interact with specific drugs; therefore, it is essential to inform healthcare professionals of any other medications being taken.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. Proper storage will help preserve the medication's efficacy and safety.
This medicine is a white or off-white, oval-shaped tablet that is biconvex.
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Genuwon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.